FDA Adverse Event Injury Summary report: N

ACL TOP 700

MDR report key: 7064403 · Received November 28, 2017

Report

Report Number
1217183-2017-00007
Event Type
Injury
Date Received
November 28, 2017
Date of Event
October 29, 2017
Report Date
November 27, 2017
Manufacturer
INSTRUMENTATION LABORATORY
Product Code
GKP
UDI-DI
08426950497974
PMA / PMN Number
K160276
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

AN INVESTIGATION WAS CONDUCTED THAT INCLUDED A REVIEW OF THE INSTRUMENT DATA. REVIEW OF THE DATA CONCLUDED THAT THE VALUES OBTAINED ON THE ACL TOP 700 WERE APPROPRIATELY DETERMINED BY THE ANALYZER AND THE INSTRUMENT WAS PERFORMING AS INTENDED. WHILE THE ROOT CASE CANNOT BE DETERMINED, THERE ARE MANY VARIABLES THAT HAVE THE POTENTIAL TO INFLUENCE THE RESULT RECOVERIES. THESE MAY INCLUDE, BUT NOT LIMITED TO, THE ACCURACY OF THE RECONSTITUTION OF THE REAGENTS AND CLEANING MATERIALS USED, THE ONBOARD STABILITY OF MATERIALS USED, REAGENT AND/OR SAMPLE HANDLING, AND SAMPLE INTEGRITY ALL OF WHICH COULD HAVE CONTRIBUTED TO THE GENERATED FINDINGS. BASED ON THE ABOVE, THERE WAS NO INDICATION OF AN INSTRUMENT MALFUNCTION AND NO REMEDIAL ACTION IS NEEDED.

Description of Event or Problem · 1

A CUSTOMER REPORTED THAT THEIR ACL TOP 700 REPORTED 2 ERRONEOUSLY LOW APTT PATIENT RESULTS USING HEMOSIL SYNTHASIL. ONE PATIENT WAS GIVEN ADDITIONAL HEPARIN DUE TO THE LOWER RESULTS. HOWEVER, THERE WAS NO ADVERSE EFFECTS DUE TO THE EXTRA HEPARIN. THE RESULTS DID NOT MATCH PATIENT HISTORY AND WAS THEREFORE REPEATED. THE 2 SAMPLES WERE SUBSEQUENTLY CORRECTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
844316 ACL TOP 700 ACL TOP GKP INSTRUMENTATION LABORATORY 2800-10 08426950497974

Patients

Seq Age Sex Outcome Treatment
1 65 YR